<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The class III <z:chebi fb="0" ids="15358">histone</z:chebi> deacetylase SIRT1 is a <z:chebi fb="0" ids="13389">nicotinamide adenine dinucleotide</z:chebi> (<z:chebi fb="0" ids="15846">NAD(+)</z:chebi>)-dependent deacetylase, and has been reported to serve diverse roles in various biological processes, such as caloric restriction, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, neuronal protection, cell growth, differentiation and <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>With respect to <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e>, there have been conflicting data supporting whether SIRT1 act as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> promoter or as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: SIRT1 protein expression, determined by immunohistochemistry, was investigated in human <z:mpath ids='MPATH_458'>normal</z:mpath> colonic mucosa, <z:mpath ids='MPATH_270'>adenoma</z:mpath>, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and metastatic tissue samples </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> <z:mpath ids='MPATH_458'>normal</z:mpath> colonic mucosa showed SIRT1 expression with no exception, and 42 (80.8%) of 52 <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath> were positive for SIRT1 </plain></SENT>
<SENT sid="4" pm="."><plain>However, only 208 (41.9%) of 497 colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> were positive </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, 45 (35.7%) of 126 metastatic tissues were positive </plain></SENT>
<SENT sid="6" pm="."><plain>Collectively, the SIRT1 expression was gradually decreased during <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumour progression</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The associations between SIRT1 expression and clinicopathological parameters revealed that loss of SIRT1 expression was associated with proximal <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> location, mucinous histology and defective mismatch repair protein expression </plain></SENT>
<SENT sid="8" pm="."><plain>This suggests that loss of SIRT1 expression is associated with the microsatellite instability phenotype of colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>In survival analyses, the loss of SIRT1 expression was significantly associated with overall survival (p=0.027, log-rank test) in univariable analysis, but multivariable analysis failed to achieve significance </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: SIRT1 expression was gradually decreased during the <z:mpath ids='MPATH_458'>normal</z:mpath>-<z:mpath ids='MPATH_270'>adenoma</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp>-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> sequence, suggesting a possible role of SIRT1 in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppression in the colorectum, and a probable link to the microsatellite instability pathway </plain></SENT>
</text></document>